. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
November 12, 2004 1/3 No: SN. 130/2019 21 November 2019 Subject: Clarification of Operating Results and Financial Position of the year ended September 30, 2019 Attention: President The Stock Exchange
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
investors will help drive stable and sustainable investments in the Thai capital market. These measures will ensure Thailand’s stock market remains fundamental to the nation’s sustainable economic growth.”
Our Ref: TL015/02 Our Ref: TL012/18 August 14, 2018 The Stock Exchange of Thailand 93, The Stock Exchange of Thailand Building Ratchadapisek Road, Dindaeng Bangkok 10400 Attention: The President Dear
undertaking as well as to protect investors? best interest.?The four key areas are:?1. Provisions on Stock Exchange: The proposed revisions include (1) granting the power to approve the rules on securities
sales were at THB 6,328 million, where the growth was accelerated to +7.2% YoY. In domestic markets, beverages and personal care continued their growth momentum at 9.4% and 5.8% respectively, while
MD&A - EN Report (Presentation) (1) 3Q24 MD&A Advanced Info Service Plc. 1 Executive Summary Sustaining core business growth alongside economic stability 3Q24 showed a modest growth in the Thai
Manager of the Stock Exchange of Thailand For the Q3/2019 period ended of September 30, 2019 (9 months) operating result of the company net loss Baht 0.22 Million comparison with the previous Q3/2018’s net